Prof. Dr. Begüm Nurpelin SAĞLIK ÖZKAN is an Associate Professor at the Faculty of Pharmacy, Anadolu University, where she also completed her Ph.D. in Pharmaceutical Chemistry (2019). Her research focuses on the design and development of novel chemical series for neurodegenerative diseases, particularly Alzheimer’s.
Dr. Sağlık Özkan has extensive experience in managing TÜBİTAK and BAP projects and holds two registered patents in pharmaceutical chemistry. She has been recognized with multiple Academic Excellence Awards (2020-2025). Her expertise bridges Computer-Aided Drug Design (CADD) and experimental medicinal chemistry. She possesses advanced proficiency in high-precision molecular docking, molecular dynamics (MD) simulations, and protein-ligand interaction analyses.
Her multidisciplinary approach combines rational drug design and multi-step organic synthesis (NMR, HRMS, IR) with comprehensive biological activity profiling. She personally conducts inhibition assays for various enzymes, including Cholinesterases (AChE/BChE), MAO-A/B, COX-1/2, and Kinases. Her work further extends to antioxidant, anticancer, and antimicrobial screenings, focusing on the therapeutic indices and selectivity of new drug candidates. Detailed portfolio and bibliometric data are available via the links below:
• AVESİS: https://avesis.anadolu.edu.tr/bnsaglik
• ORCID: 0000-0002-0151-6266
• Web of Science: HPF-4762-2023
• Google Scholar: MVfpQ98AAAAJ
Prof. Dr. Begüm Nurpelin SAĞLIK ÖZKAN is an Associate Professor at the Faculty of Pharmacy, Anadolu University, where she also completed her Ph.D. in Pharmaceutical Chemistry (2019). Her research focuses on the design and development of novel chemical series for neurodegenerative diseases, particularly Alzheimer’s.
Dr. Sağlık Özkan has extensive experience in managing TÜBİTAK and BAP projects and holds two registered patents in pharmaceutical chemistry. She has been recognized with multiple Academic Excellence Awards (2020-2025). Her expertise bridges Computer-Aided Drug Design (CADD) and experimental medicinal chemistry. She possesses advanced proficiency in high-precision molecular docking, molecular dynamics (MD) simulations, and protein-ligand interaction analyses.
Her multidisciplinary approach combines rational drug design and multi-step organic synthesis (NMR, HRMS, IR) with comprehensive biological activity profiling. She personally conducts inhibition assays for various enzymes, including Cholinesterases (AChE/BChE), MAO-A/B, COX-1/2, and Kinases. Her work further extends to antioxidant, anticancer, and antimicrobial screenings, focusing on the therapeutic indices and selectivity of new drug candidates. Detailed portfolio and bibliometric data are available via the links below:
• AVESİS: https://avesis.anadolu.edu.tr/bnsaglik
• ORCID: 0000-0002-0151-6266
• Web of Science: HPF-4762-2023
• Google Scholar: MVfpQ98AAAAJ